IFM Investors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.83M | Sell |
36,263
-2,258
| -6% | -$432K | 0.05% | 307 |
|
|
2026
Q1 | $7.06M | Sell |
38,521
-1,334
| -3% | -$246K | 0.06% | 291 |
|
|
2025
Q4 | $7.01M | Buy |
39,855
+2,365
| +6% | +$386K | 0.06% | 286 |
|
|
2025
Q3 | $5.15M | Buy |
37,490
+1,738
| +5% | +$235K | 0.05% | 334 |
|
|
2025
Q2 | $4.49M | Buy |
35,752
+2,023
| +6% | +$252K | 0.04% | 361 |
|
|
2025
Q1 | $4.62M | Buy |
33,729
+304
| +0.9% | +$43.5K | 0.05% | 343 |
|
|
2024
Q4 | $5.11M | Sell |
33,425
-588
| -2% | -$99.2K | 0.05% | 332 |
|
|
2024
Q3 | $6.59M | Sell |
34,013
-247
| -0.7% | -$51.7K | 0.06% | 296 |
|
|
2024
Q2 | $7.94M | Buy |
34,260
+72
| +0.2% | +$15.6K | 0.08% | 232 |
|
|
2024
Q1 | $7.37M | Hold |
34,188
| – | – | 0.08% | 253 |
|
|
2023
Q4 | $8.85M | Buy |
34,188
+1,113
| +3% | +$273K | 0.11% | 189 |
|
|
2023
Q3 | $8.5M | Buy |
33,075
+1,662
| +5% | +$445K | 0.11% | 180 |
|
|
2023
Q2 | $8.95M | Sell |
31,413
-431
| -1% | -$128K | 0.12% | 175 |
|
|
2023
Q1 | $8.85M | Buy |
31,844
+803
| +3% | +$222K | 0.13% | 154 |
|
|
2022
Q4 | $8.6M | Buy |
31,041
+3,231
| +12% | +$913K | 0.14% | 153 |
|
|
2022
Q3 | $7.42M | Buy |
27,810
+977
| +4% | +$207K | 0.13% | 157 |
|
|
2022
Q2 | $5.47M | Buy |
26,833
+3,236
| +14% | +$662K | 0.1% | 219 |
|
|
2022
Q1 | $4.97M | Buy |
23,597
+3,376
| +17% | +$734K | 0.08% | 260 |
|
|
2021
Q4 | $4.85M | Sell |
20,221
-228
| -1% | -$58.6K | 0.09% | 223 |
|
|
2021
Q3 | $5.79M | Sell |
20,449
-80
| -0.4% | -$26.2K | 0.12% | 166 |
|
|
2021
Q2 | $7.11M | Buy |
20,529
+3,236
| +19% | +$980K | 0.15% | 143 |
|
|
2021
Q1 | $4.84M | Buy |
17,293
+1,831
| +12% | +$494K | 0.13% | 153 |
|
|
2020
Q4 | $3.79M | Buy |
15,462
+1,662
| +12% | +$429K | 0.12% | 160 |
|
|
2020
Q3 | $3.92M | Buy |
13,800
+796
| +6% | +$222K | 0.16% | 129 |
|
|
2020
Q2 | $3.48M | Sell |
13,004
-5,437
| -29% | -$1.63M | 0.18% | 120 |
|
|
2020
Q1 | $5.83M | Sell |
18,441
-1,222
| -6% | -$371K | 0.26% | 86 |
|
|
2019
Q4 | $5.83M | Sell |
19,663
-1,521
| -7% | -$422K | 0.21% | 102 |
|
|
2019
Q3 | $4.93M | Buy |
21,184
+7,013
| +49% | +$1.63M | 0.18% | 124 |
|
|
2019
Q2 | $3.31M | Buy |
14,171
+802
| +6% | +$185K | 0.19% | 118 |
|
|
2019
Q1 | $3.16M | Buy |
13,369
+1,482
| +12% | +$467K | 0.2% | 108 |
|
|
2018
Q4 | $3.58M | Buy |
11,887
+763
| +7% | +$244K | 0.29% | 76 |
|
|
2018
Q3 | $3.93M | Buy |
11,124
+1,592
| +17% | +$548K | 0.3% | 73 |
|
|
2018
Q2 | $2.77M | Buy |
9,532
+2,947
| +45% | +$829K | 0.26% | 81 |
|
|
2018
Q1 | $1.8M | Buy |
6,585
+651
| +11% | +$202K | 0.26% | 88 |
|
|
2017
Q4 | $1.89M | Sell |
5,934
-96
| -2% | -$30.8K | 0.3% | 73 |
|
|
2017
Q3 | $1.89M | Buy |
6,030
+81
| +1% | +$24K | 0.32% | 72 |
|
|
2017
Q2 | $1.61M | Buy |
5,949
+1,491
| +33% | +$394K | 0.29% | 80 |
|
|
2017
Q1 | $1.22M | Buy |
4,458
+1,604
| +56% | +$454K | 0.31% | 76 |
|
|
2016
Q4 | $809K | Buy |
+2,854
| New | +$846K | 0.38% | 64 |
|
Other funds holding BIIB
AIM
AAMU
ADEF
BPC
HP
IFM Investors's BIIB Position: Q2 2026 in Review
IFM Investors reduced its Biogen (BIIB) stake by 5.9% in Q2 2026, selling an estimated $432K and leaving 36,263 shares worth $7.83M. The position accounts for 0.05% of the portfolio, ranked #307.
IFM Investors first reported a position in BIIB in Q4 2016 and has held it in 39 quarters since. The position peaked at $8.95M in Q2 2023. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- IFM Investors held 36,263 shares of Biogen worth $7.83M as of Q2 2026.
- IFM Investors sold 2,258 Biogen shares in Q2 2026, an estimated $432K.
- Biogen made up 0.05% of IFM Investors's portfolio in Q2 2026, its #307 holding.
- IFM Investors first reported a position in Biogen in Q4 2016 and has held it in 39 quarters since.
- IFM Investors's Biogen position peaked at $8.95M in Q2 2023.
- 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.